Tamoxifen-related porphyria cutanea tarda

Author： Agarwal R.   Peters T.   Coombes R.   Vigushin D.  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.19, Iss.2, 2002-06, pp. : 121-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Switching from Tamoxifen to Anastrozole on Tamoxifen-Related Endocrine Symptoms and Quality of Life: In Early Breast Cancer Patients

By Massacesi Cristian  

American Journal of Cancer, Vol. 5, Iss. 6, 2006-01 ,pp. : 433-440

Adis International

Access to resources Recommend Favorite

Tamoxifen and arrhythmia

By Slovacek Ladislav  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1431-1432

Humana Press, Inc

Access to resources Recommend Favorite

Whither Tamoxifen

By Edmonson J.H.  

Gynecologic Oncology, Vol. 62, Iss. 1, 1996-07 ,pp. : 1-3

Academic Press

Access to resources Recommend Favorite

Tamoxifen and Cataracts: A Null Association

By Bradbury Brian D.   Lash Timothy L.  

Breast Cancer Research and Treatment, Vol. 87, Iss. 2, 2004-09 ,pp. : 189-196

Springer Publishing Company

Access to resources Recommend Favorite

The rise of tamoxifen: Temporal and geographical trends of tamoxifen use in Ontario

By Palda V.A.   Goel V.   Sawka C.A.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 1, 1997-03 ,pp. : 33-41

Springer Publishing Company

Access to resources Recommend Favorite